British medical journal (Clinical research ed.)
-
Br Med J (Clin Res Ed) · Oct 1983
Randomized Controlled Trial Comparative Study Clinical TrialComparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
Sulphasalazine was first formulated by Svartz in the early 1940s, specifically for use as a remission inducing drug in rheumatoid arthritis. After the publication of an unfavourable trial, however, the drug was restricted to patients with ulcerative colitis. In the late 1970s sulphasalazine was re-examined in rheumatoid arthritis and favourable results reported in "open" trials. ⋯ No potentially dangerous effects of sulphasalazine were encountered in contrast with those seen in the penicillamine group. The results suggest that sulphasalazine is an effective and safe drug capable of producing remissions in active rheumatoid arthritis. They also lend confidence to the use of preliminary "open" trials as a means of screening for remission inducing drugs in rheumatoid arthritis.
-
Br Med J (Clin Res Ed) · Aug 1983
Cardowan coal mine explosion: experience of a mass burns incident.
A coal mine explosion 1700 feet (516 m) underground and two miles (3.2 km) from the pit head resulted in 40 casualties. Two hours elapsed between the explosion and the arrival of patients at hospital. Six patients suffered mechanical injuries, only one of which was life threatening. ⋯ The average length of inpatient stay in those admitted was 24 days. Early assessment and treatment in the accident and emergency department was relatively simple because of the large proportion of burn injuries. Lack of communication between site and hospital made administration of the disaster difficult.